Skip to main content

Want a detailed portfolio tracker?

Addex Therapeutics (ADXN) P/E (2020 - 2026)

Addex Therapeutics (ADXN) P/E from Jan 29, 2020 to Jul 21, 2026. The TTM Addex Therapeutics (ADXN) P/E is -3.77. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Addex Therapeutics (ADXN)

YearP/EChange
2026-3.77+19.67%
2025-3.15-61.48%
2024-8.19+15.70%
2023-7.08-51.99%
2022-14.74-89.98%
2021-147.13-53.06%
2020-313.45N/A

Comparison Addex Therapeutics (ADXN) P/E with competitors

Addex Therapeutics (ADXN) P/E is -3.77.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.05%
NBYStablecoin Development Corp0.00-100.11%
ENLVEnlivex Ltd0.07-101.98%
FGENFibroGen Inc0.24-106.36%
CHRSCoherus Biosciences Inc0.85-122.48%
FBIOFortress Biotech Inc0.95-125.14%
ORMPOramed Pharmaceuticals Inc1.50-139.82%
AGENAgenus Inc3.01-179.74%
INVAInnoviva Inc3.15-183.56%
VXRTVaxart Inc3.55-194.04%
CRMDCorMedix Inc3.63-196.13%
CVACCureVac N.V.4.45-217.78%
GLPGGalapagos NV4.86-228.73%
SRPTSarepta Therapeutics Inc4.88-229.34%
ABEOAbeona Therapeutics Inc5.39-242.73%
ABUSArbutus Biopharma Corp5.60-248.25%
ZVRAZevra Therapeutics Inc5.89-255.97%
SPROSpero Therapeutics Inc6.23-265.01%
CGENCompugen Ltd6.31-267.28%
RIGLRigel Pharmaceuticals6.87-282.06%
SLXNSilexion Therapeutics Corp7.30-293.30%
OMEROmeros Corporation9.26-345.30%
AUPHAurinia Pharmaceuticals Inc9.58-353.94%
PLXProtalix BioTherapeutics Inc10.89-388.54%
ACADAcadia Pharmaceuticals Inc11.73-410.73%
TBPHTheravance Biopharma Inc12.26-424.87%
HRMYHarmony Biosciences Holdings Inc13.82-466.15%
SABSSAB Biotherapeutics Inc14.14-474.52%
NAGENiagen Bioscience Inc14.82-492.58%
INCYIncyte Corp15.82-519.20%
REGNRegeneron Pharmaceuticals Inc15.86-520.10%
PBYIPuma Biotechnology Inc17.32-558.75%
CPRXCatalyst Pharmaceuticals Inc17.44-562.03%
EXELExelixis Inc17.54-564.64%
TGTXTG Therapeutics Inc18.97-602.48%
MDXGMimedx Group Inc20.55-644.51%
XOMAXOMA Royalty Corp22.87-706.05%
ARGXArgen X SE24.30-743.76%
CTMXCytomX Therapeutics Inc24.82-757.62%
XOMAOXOMA Royalty Corp25.34-771.49%
HALOHalozyme Therapeutics Inc25.62-778.88%
XOMAPXOMA Royalty Corp25.67-780.11%
VRTXVertex Pharmaceuticals Inc27.99-841.70%
RPRXRoyalty Pharma plc - Class A28.69-860.05%
SLNOSoleno Therapeutics Inc29.02-868.74%
ASNDAscendis Pharma A/S30.09-897.09%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1104.45%
APLSApellis Pharmaceuticals Inc39.02-1133.84%
BMRNBiomarin Pharmaceutical Inc42.21-1218.37%
KRYSKrystal Biotech Inc45.34-1301.34%
ONCBeiGene Ltd69.54-1942.42%
PHARPharming Group N.V.75.03-2087.75%
TECHBio-Techne Corp101.96-2801.31%
VCELVericel Corp109.92-3012.29%
ALNYAlnylam Pharmaceuticals Inc117.96-3225.40%
GMABGenmab140.29-3816.90%
TLXTelix Pharmaceuticals Ltd162.15-4396.12%
CORTCorcept Therapeutics Inc212.86-5739.51%